Effective biologics against all pandemic-potential pathogens

Panoplia was started by a team of scientists and engineers to expand the reach and impact of broad-spectrum medicines for infectious diseases. Panoplia’s mission is to reduce pandemic threats by creating broad-spectrum antivirals. We focus on developing inhalable antivirals that provide extended prophylaxis, remain dormant until infection, and target the most conserved viral properties.

Our Team

  • Brian Wang

    Executive Director

  • Joe Torres

    Program Lead

  • Kenza Samlali

    Product Developer

  • Alex Norman

    Scientist

  • Alex Kleinman

    Scientist

Our Board

Aleš Flídr (Chair), Jacob Swett (Treasurer), Will Bradshaw (Secretary)

We are supported by

How you can help.

Partner with us.

We partner with scientific and manufacturing organizations to develop new technologies that align with our mission and out-license technologies for impact.

Donate.

We accept tax-deductible donations through Players Philanthropy Fund, our fiscal sponsor.